Markers of vascular perturbation correlate with airway structural change in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 2, 2013, Pages 167-178

  Johansson, Mats W ^a   Kruger, Stanley J ^a   Schiebler, Mark L ^b   Evans, Michael D ^a   Sorkness, Ronald L ^b   Denlinger, Loren C ^a   Busse, William W ^a   Jarjour, Nizar N ^a   Montgomery, Robert R ^c,d   Mosher, Deane F ^a   Fain, Sean B ^a,b,e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e University of Wisconsin Madison   (United States)

Author keywords

Asthma; Computed tomography; Magnetic resonance imaging; P selectin; Von Willebrand factor

Indexed keywords

HELIUM; PADGEM PROTEIN; THROMBOCYTE FACTOR 4; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; ASTHMA; CELLULAR PARAMETERS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIAL CELL PERTURBATION;

ADULT; ASTHMA; BRONCHI; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; P-SELECTIN; PLATELET FACTOR 4; PROTEIN PRECURSORS; TOMOGRAPHY, X-RAY COMPUTED; VON WILLEBRAND FACTOR;

EID: 84881157401     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201301-0185OC     Document Type: Article

References (70)

1. Aysola RS, Hoffman EA, Gierada D, Wenzel S, Cook-Granroth J, Tarsi J, Zheng J, Schechtman KB, Ramkumar TP, Cochran R, et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest 2008;134: 1183-1191.
2. Fain SB, Gonzalez-Fernandez G, Peterson ET, Evans MD, Sorkness RL, Jarjour NN, Busse WW, Kuhlman JE. Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Acad Radiol 2008;15: 753-762.
3. Busacker A, Newell JD Jr, Keefe T, Hoffman EA, Granroth JC, Castro M, Fain S, Wenzel S. A multivariate analysis of risk factors for the airtrapping asthmatic phenotype as measured by quantitative CT analysis. Chest 2009;135: 48-56.
4. Holmes JH, O'Halloran RL, Brodsky EK, Bley TA, Francois CJ, Velikina JV, Sorkness RL, Busse WW, Fain SB. Three-dimensional imaging of ventilation dynamics in asthmatics using multiecho projection acquisition with constrained reconstruction. Magn Reson Med 2009;62: 1543-1556.
5. Fain S, Schiebler ML, McCormack DG, Parraga G. Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: review of current and emerging translational methods and applications. J Magn Reson Imaging 2010;32: 1398-1408.
6. Castro M, Fain SB, Hoffman EA, Gierada DS, Erzurum SC, Wenzel S; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Lung imaging in asthmatic patients: the picture is clearer. J Allergy Clin Immunol 2011;128: 467-478.
7. de Lange EE, Altes TA, Patrie JT, Gaare JD, Knake JJ, Mugler JP III, Platts-Mills TA. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130: 1055-1062.
8. Hoffman EA, Simon BA, McLennan G. State of the art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3: 519-532.
9. Jarjour NN, Erzurum SC, Bleecker ER, Calhoun WJ, Castro M, Comhair SA, Chung KF, Curran-Everett D, Dweik RA, Fain SB, et al.; NHLBI Severe Asthma Research Program (SARP). Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 2012;185: 356-362.
10. Gevenois PA, De Vuyst P, de Maertelaer V, Zanen J, Jacobovitz D, Cosio MG, Yernault JC. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154: 187-192.
11. Bankier AA, Madani A, Gevenois PA. CT quantification of pulmonary emphysema: assessment of lung structure and function. Crit Rev Computed Tomogr 2002;43: 399-417.
12. Mitsunobu F, Mifune T, Ashida K, Hosaki Y, Tsugeno H, Okamoto M, Harada S, Takata S, Tanizaki Y. Influence of age and disease severity on high resolution CT lung densitometry in asthma. Thorax 2001;56: 851-856.
13. Mitsunobu F, Mifune T, Ashida K, Hosaki Y, Tsugeno H, Okamoto M, Harada S, Tanizaki Y. Low-attenuation areas of the lungs on highresolution computed tomography in asthma. J Asthma 2001;38: 413-422.
14. Mitsunobu F, Ashida K, Hosaki Y, Tsugeno H, Okamoto M, Nishida K, Takata S, Yokoi T, Mishima M, Tanizaki Y. Complexity of terminal airspace geometry assessed by computed tomography in asthma. Am J Respir Crit Care Med 2003;167: 411-417.
15. Mitsunobu F, Ashida K, Hosaki Y, Tsugeno H, Okamoto M, Nishida N, Nagata T, Takata S, Tanizaki Y. Decreased computed tomographic lung density during exacerbation of asthma.Eur Respir J 2003;22: 106-112.
16. Mitsunobu F, Tanizaki Y. The use of computed tomography to assess asthma severity. Curr Opin Allergy Clin Immunol 2005;5: 85-90.
17. Ueda T, Niimi A, Matsumoto H, Takemura M, Hirai T, Yamaguchi M, Matsuoka H, Jinnai M, Muro S, Chin K, et al. Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol 2006;118: 1019-1025.
18. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997;156: 229-233.
19. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161: 1720-1745.
20. Tanaka H, Yamada G, Saikai T, Hashimoto M, Tanaka S, Suzuki K, Fujii M, Takahashi H, Abe S. Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. Am J Respir Crit Care Med 2003;168: 1495-1499.
21. Bailey SR, Boustany S, Burgess JK, Hirst SJ, Sharma HS, Simcock DE, SuravaramPR, Weckmann M. Airway vascular reactivity and vascularisation in human chronic airway disease. Pulm Pharmacol Ther 2009;22: 417-425.
22. Bischof RJ, Bourke JE, Hirst SJ, Meeusen EN, Snibson KJ, Van Der Velden J. Measurement and impact of remodeling in the lung: airway neovascularization in asthma. Proc Am Thorac Soc 2009;6: 673-677.
23. Paredi P, Barnes PJ. The airway vasculature: recent advances and clinical implications. Thorax 2009;64: 444-450.
24. Ribatti D, Puxeddu I, Crivellato E, Nico B, Vacca A, Levi-Schaffer F. Angiogenesis in asthma. Clin Exp Allergy 2009;39: 1815-1821.
25. Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 2010;65: 946-958.
26. Park HS, Kim SY, Kim SR, Lee YC. Targeting abnormal airway vascularity as a therapeutical strategy in asthma. Respirology 2010; 15: 459-471.
27. Asosingh K, Cheng G, Xu W, Savasky BM, Aronica MA, Li X, Erzurum SC. Nascent endothelium initiates Th2 polarization of asthma. J Immunol 2013;190: 3458-3465.
28. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994;94: 427-438, quiz 439.
29. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994;55: 662-675.
30. van Mourik JA, Romani de Wit T. Von Willebrand factor propeptide in vascular disorders. Thromb Haemost 2001;86: 164-171.
31. Haberichter SL, Shi Q, Montgomery RR. Regulated release of VWF and FVIII and the biologic implications. Pediatr Blood Cancer 2006;46: 547-553.
32. Boldy DA, Short PE, Cowen P, Hill FG, Chambers DC, Ayres JG. Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population. Respir Med 1998;92: 395-400.
33. Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, Luce JM, Montgomery AB, Marks JD, Matthay MA. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990;86: 474-480.
34. Lopes AA, Maeda NY. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension. Chest 1998;114: 1276-1282.
35. André P. P-selectin in haemostasis. Br J Haematol 2004;126: 298-306.
36. Kappelmayer J, Nagy B Jr, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004;42: 475-486.
37. Kowal K, Pampuch A, Kowal-Bielecka O, DuBuske LM, BodzentaŁukaszyk A. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin Exp Allergy 2006;36: 426-432.
38. Zietkowski Z, Skiepko R, Tomasiak MM, Bodzenta-Lukaszyk A. Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction. J Investig Allergol Clin Immunol 2008;18: 272-278.
39. Yu H, Ren J, Wang F, Liu L, Wu S, Liu Y. [P-selectin and tachykinins in bronchial hyperresponsiveness of asthma]. Zhonghua Nei Ke Za Zhi 1999;38: 228-230.
40. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14: 506-512.
41. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel- Palade bodies. J Clin Invest 1989;84: 92-99.
42. Hippenstiel S, Krüll M, Ikemann A, Risau W, Clauss M, Suttorp N. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol 1998;274:L678-L684.
43. Kneuer C, Ehrhardt C, Radomski MW, Bakowsky U. Selectins - potential pharmacological targets? Drug Discov Today 2006;11: 1034-1040.
44. Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR. Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. J Thromb Haemost 2012;10: 1646-1652.
45. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al.; National Heart, Lung, Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119: 405-413.
46. Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Erzurum SC, Gaston BM, Israel E, et al.; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008;104: 394-403.
47. Gauvreau GM, Evans MY. Allergen inhalation challenge: a human model of asthma exacerbation. Contrib Microbiol 2007;14: 21-32.
48. Johansson MW, Han ST, Gunderson KA, Busse WW, Jarjour NN, Mosher DF. Platelet activation, P-selectin, and eosinophil b1- integrin activation in asthma. Am J Respir Crit Care Med 2012;185: 498-507.
49. Page C, Pitchford S. Platelets coming of age: implications for our understanding of allergic inflammation. Am J Respir Crit Care Med 2013;187: 459-460.
50. Johansson MW, Kruger SJ, Montgomery RR, Evans MD, Mosher DF, Busse WW, Fain SB, Jarjour NN. Markers of vascular perturbation correlate with airway structural change in asthma [abstract]. Am J Respir Crit Care Med 2011;183:A4371.
51. Johansson MW, Han S-T, Gunderson KA, Montgomery RR, Busse WW, Jarjour NN, Mosher DF. Platelet activation, P-selectin mobilization, and eosinophil beta1 integrin activation occur in asthma and are associated with clinical phenotypes [abstract]. Am J Respir Crit Care Med 2011;183:A4335.
52. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162: 2341-2351.
53. Haberichter SL, Balistreri M, Christopherson P, Morateck P, Gavazova S, Bellissimo DB, Manco-Johnson MJ, Gill JC, Montgomery RR. Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood 2006;108: 3344-3351.
54. Siegel S. Nonparametric statistics for the behavioral sciences. New York, NY: McGraw-Hill; 1956.
55. Nusinow SR, Federici AB, Zimmerman TS, Curd JG. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 1984;27: 1405-1410.
56. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003;101: 2089-2093.
57. Sadler JE. Low von Willebrand factor: sometimes a risk factor and sometimes a disease. Hematology (Am Soc Hematol Educ Program) 2009: 106-112.
58. Kruger SJ, Niles D, Evans MD, Jarjour NN, Busse WW, Dattawadkar A, Sorkness RL, Fain SB. MRI and CT imaging of lung structure and function show regional differences in mild/moderate and severe asthma [abstract]. Am J Respir Crit Care Med 2011;183:A5170.
59. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, et al.; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181: 315-323.
60. Brown RH, Pearse DB, Pyrgos G, Liu MC, Togias A, Permutt S. The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol 2006;101: 30-39.
61. de Lange EE, Altes TA, Patrie JT, Battiston JJ, Juersivich AP, Mugler JP III, Platts-Mills TA. Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology 2009;250: 567-575.
62. Cleator JH, Zhu WQ, Vaughan DE, Hamm HE. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. Blood 2006;107: 2736-2744.
63. Liu J, Yuan L, Molema G, Regan E, Janes L, Beeler D, Spokes KC, Okada Y, Minami T, Oettgen P, et al. Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. Blood 2011;117: 342-351.
64. Ochoa CD, Wu S, Stevens T. New developments in lung endothelial heterogeneity: von Willebrand factor, P-selectin, and the Weibel- Palade body. Semin Thromb Hemost 2010;36: 301-308.
65. Sun Y, Wang J, Li H, Han X. Found in inflammatory zone 1 induces angiogenesis in murine models of asthma. Lung 2008;186: 375-380.
66. Moldobaeva A, Jenkins J, Wagner E. Effects of distension on airway inflammation and venular P-selectin expression. Am J Physiol Lung Cell Mol Physiol 2008;295:L941-L948.
67. Stevens T. Functional and molecular heterogeneity of pulmonary endothelial cells. Proc Am Thorac Soc 2011;8: 453-457.
68. Eikenboom J, Federici AB, Dirven RJ, Castaman G, Rodeghiero F, Budde U, Schneppenheim R, Batlle J, Canciani MT, Goudemand J, et al.; MCMDM-1VWD Study Group. VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease. Blood 2013;121: 2336-2339.
69. Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, Hayward C, Rudan I, Sabater-Lleal M, Bis JC, et al.; Wellcome Trust Case Control Consortium. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 2010; 121: 1382-1392.
70. Corrigan CJ, Wang W, Meng Q, Fang C, Wu H, Reay V, Lv Z, Fan Y, An Y, Wang YH, et al. T-helper cell type 2 (Th2) memory T cellpotentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci USA 2011;108: 1579-1584.